AEHR's Record Backlog Highlights Unproven Shipment Execution Ahead of Q1 FY27 Earnings

What happened

Aehr Test Systems will report fiscal Q1 2027 results with a record backlog driven by AI processors, silicon photonics, and data center demand, but the prior DeepValue report cautioned that bookings have not yet translated into consistent shipment cadence. The most recent quarter showed revenue falling 44% year-over-year to $10.3 million and a net loss of $3.2 million, despite strong order announcements. The stock has already surged to $115.3 in June 2026, pricing in a steep acceleration that requires proof of Sonoma system shipments and margin recovery. Customer concentration remains high, with one customer representing over 40% of quarterly revenue, and purchase orders are cancellable with limited penalties. This earnings release will be pivotal: investors need to see sequential revenue acceleration above $20 million, improving gross margin, and evidence that the upgraded contract manufacturing facility is delivering systems on schedule.

Implication

Investors should focus on whether revenue exceeds $20 million sequentially, gross margin expands, and the largest customer's revenue share declines below 40%, signaling diversification. A failure to show these proofs could trigger a re-rating toward the bear case of $85, while strong execution could support the base case of $115 with potential upside to $135. Any new equity issuance after the recent ATM completion would further dilute per-share value and signal that the ramp is not self-funded. The crowded narrative around AI burn-in testing has driven the stock up nearly 880% over the past year, making it vulnerable to disappointments. We maintain a WAIT rating with an attractive entry near $80, and we would only turn constructive with concrete evidence of shipment cadence and margin inflection.

Thesis delta

The thesis remains unchanged: the stock is a WAIT until Aehr demonstrates that record bookings convert into reported revenue and profitability. The upcoming Q1 FY27 earnings are a critical test, and the news of a record backlog does not alter the need for shipment and margin proof. The risk-reward remains skewed to the downside at current levels if execution lags.